Script section containing code for Liveperson Chat Solution

Hoover's - A D&B Company - We Make It Easier
Buy Reports For This Company

ArQule, Inc.
WoburnMA United States
  (NASDAQ: ARQL)

btn-overview-2btn-people-1btn-competition-1btn-financials-1

Company Description

ArQule is pursuing a drug research major in molecular biology, with a focus on cancer cell termination. The biotechnology firm works independently and with other drugmakers to discover new potential drug compounds based on its cancer-inhibiting technology platform. ArQule is developing a portfolio of oncology drugs, with a handful of anti-cancer compounds undergoing clinical trials. It is testing its most advanced candidate, ARQ 197, as a treatment for a variety of tumor types such as non-small cell lung cancer and colorectal cancer through a partnership with Daiichi Sankyo.

19 Presidential WayPhone: 781-994-0300http://www.arqule.com
WoburnMA 01801Fax: 781-376-6019Map Map This Company
United States

Try a Full Premium Subscription

Access over 85 million companies
Call (866) 443-3939 or

btn-free-trial

Prepare for your Sales call

Try a Small Business Subscription
Starting $89 per month

btn-subscribe-now

ArQule, Inc. Rankings

S&P 600Russell 2000 (June 2011)

Executives

20 executives listed for ArQule, Inc.'s Woburn, MA location.
ChairmanPatrick ZennerE-mail
CEO and DirectorPaolo PucciE-mail
President, COO, General Counsel, and SecretaryPeter LawrenceE-mail

More ArQule, Inc. Executives

Financials

Company TypePublic - NASDAQ: ARQL Headquarters
Fiscal Year-EndDecember
2011 Employees103
More ArQule, Inc. Financials
D&B logoDNBi

Leverage D&B's credit assessment tools to positively impact
your business. Get the scoop on ArQule, Inc. now.

  • Reduce risk.
  • Drive greater profitability.
  • Increase cash flow.
Get a Credit Report Now

Sponsored Links